Voya Financial Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-23,576
Closed -$133K 611
2020
Q1
$133K Buy
23,576
+2,286
+11% +$20.4K 0.01% 549
2019
Q4
$193K Buy
21,290
+1,869
+10% +$15.2K 0.01% 614
2019
Q3
$141K Buy
19,421
+1,789
+10% +$12.8K 0.01% 598
2019
Q2
$139K Buy
17,632
+4,316
+32% +$51.1K 0.01% 601
2019
Q1
$167K Buy
13,316
+1,147
+9% +$18.2K 0.01% 592
2018
Q4
$240K Buy
12,169
+1,776
+17% +$41.1K 0.02% 475
2018
Q3
$293K Buy
+10,393
New +$248K 0.02% 477

Other funds holding EVH

Voya Financial Advisors's EVH Position: Q2 2020 in Review

Voya Financial Advisors sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 23,576 shares — an estimated $133K sold.

Voya Financial Advisors first reported a position in EVH in Q3 2018 and held it in 7 quarters. The position peaked at $293K in Q3 2018. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Voya Financial Advisors reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Voya Financial Advisors sold 23,576 Evolent Health shares in Q2 2020, an estimated $133K.
  • Voya Financial Advisors first reported a position in Evolent Health in Q3 2018 and held it in 7 quarters.
  • Voya Financial Advisors's Evolent Health position peaked at $293K in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Voya Financial Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.